A detailed history of Squarepoint Ops LLC transactions in Geron Corp stock. As of the latest transaction made, Squarepoint Ops LLC holds 43,400 shares of GERN stock, worth $189,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,400
Previous 392,197 88.93%
Holding current value
$189,224
Previous $827,000 82.71%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $590,429 - $1.16 Million
-337,388 Reduced 86.03%
54,809 $180,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $290,266 - $385,354
166,820 Added 74.02%
392,197 $827,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $443,992 - $831,641
225,377 New
225,377 $723,000
Q4 2022

Feb 14, 2023

SELL
$2.03 - $2.42 $75,087 - $89,513
-36,989 Reduced 63.12%
21,612 $52,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $97,863 - $172,286
58,601 New
58,601 $137,000
Q1 2022

May 16, 2022

SELL
$0.99 - $1.6 $75,016 - $121,238
-75,774 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$1.22 - $1.72 $5,927 - $8,357
4,859 Added 6.85%
75,774 $92,000
Q3 2021

Nov 15, 2021

SELL
$1.2 - $1.5 $61,690 - $77,113
-51,409 Reduced 42.03%
70,915 $97,000
Q2 2021

Aug 16, 2021

SELL
$1.25 - $1.83 $63,060 - $92,319
-50,448 Reduced 29.2%
122,324 $172,000
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $262,613 - $362,821
172,772 New
172,772 $273,000
Q3 2020

Nov 16, 2020

SELL
$1.59 - $2.19 $17,994 - $24,784
-11,317 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.05 - $2.18 $11,882 - $24,671
11,317 New
11,317 $25,000
Q4 2019

Feb 14, 2020

SELL
$1.27 - $1.54 $106,786 - $129,489
-84,084 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$1.15 - $1.59 $35,822 - $49,528
31,150 Added 58.85%
84,084 $112,000
Q2 2019

Aug 14, 2019

BUY
$1.37 - $2.02 $72,519 - $106,926
52,934 New
52,934 $75,000
Q3 2018

Nov 14, 2018

SELL
$1.76 - $6.38 $171,536 - $621,820
-97,464 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$3.29 - $4.82 $320,656 - $469,776
97,464 New
97,464 $334,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.65B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.